- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Vetter breaks ground on $285m US clinical manufacturing site | ||
| Mo | CKD anemia market expected to reach $5.3bn across the 7MM by 2034 | ||
| Mo | FDA removes safety programme for CAR-T therapies to boost uptake | ||
| Mo | Sobi gains FDA approval for Gamifant to treat HLH/MAS | ||
| Mo | Torrent Pharmaceuticals to acquire stake in JB Pharma for $3bn | ||
| 27.06. | FDA approves label updates for BMS' CAR T cell therapies | ||
| 27.06. | AI in drug discovery: from hypothetical to reality | ||
| 27.06. | Viatris gains China approval for Yupelri to treat COPD | ||
| 27.06. | Novo Nordisk teams up with WeightWatchers in latest telehealth push | ||
| 27.06. | Why can't the US figure out weight loss drug prices? | ||
| 27.06. | Porton Advanced and EVA Pharma collaborate for CAR T-cell therapies | ||
| 26.06. | BioCity's SC0062 gains NMPA breakthrough therapy designation | ||
| 26.06. | Innovation in Focus: Highlights from the Two-Day London Biotechnology Show 2025 | ||
| 26.06. | UK steps up with £1.25bn Gavi vaccine pledge as US funding disappears | ||
| 26.06. | Eli Lilly receives FDA approval for Amyvid label update | ||
| 26.06. | How AI and machine learning are transforming drug discovery | ||
| 26.06. | Novartis concludes Regulus Therapeutics acquisition | ||
| 25.06. | Gilead eyes Kymera's 'adhesive' cancer drug in $750m deal | ||
| 25.06. | Navigating uncertainty: the future of vaccine oversight amid CDC firings | ||
| 25.06. | How will RFK Jr's American dream for vaccines play out? | ||
| 25.06. | EHDS regulation will depend on strong patient confidence | ||
| 25.06. | US FDA approves GSK's Benlysta autoinjector for lupus nephritis | ||
| 25.06. | GE HealthCare's PET imaging agent gains Alzheimer's label expansion | ||
| 25.06. | Medera and Novoheart collaborate on mini-heart models for HLHS | ||
| 25.06. | Alzheimer's R&D resurgence driven by $16.8bn in acquisitions in 2025YTD |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .